Key facts
| Price (PPV) | 15.20 MAD |
|---|---|
| Dispensing status | Unscheduled — no prescription needed |
| Composition (DCI) | econazole |
| Class | Antifungals for dermatological use |
| ATC code | D01AC03 |
| Manufacturer | LAPROPHAN |
| Presentation | Tube de 25 g |
| Nature | Médicament |
| Hospital price | 9.50 MAD |
| Data collected on | 9/8/2026 |
Indications
Candidoses : Les candidoses cutanées rencontrées en clinique humaine sont habituellement dues à Candida albicans. Cependant, la mise en évidence d'un candida sur la peau ne peut constituer en soi une indication. · Traitement des mycoses des plis non macérés : intertrigo génital, sous-mammaire, inter-digital, etc. · Traitement d’appoint des mycoses des ongles : onyxis, périonyxis. Un traitement systémique antifongique associé est nécessaire. Dans certains cas, il est recommandé de traiter simultanément le tube digestif. Dermatophyties : · Traitement : o Dermatophyties de la peau glabre, o Intertrigos génitaux et cruraux non macérés, · Traitement d’appoint des teignes. Un traitement systémique antifongique associé est nécessaire. Erythrasma
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Fungilyse 1 % (LAPROPHAN) contains the same active substance as Fungilyse 1 % (Econazole) at the same strength, but in a different pack: Tube de 50 g at 28.50 MAD, i.e. 0.57 MAD per g against 0.61 MAD for Fungilyse 1 %. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Fungilyse 1 % | LAPROPHAN | Tube de 50 g | 28.50 MAD | 0.57 / g |
| Pevagine 1 % | PHARMA5 | Tube de 30 g | 29.50 MAD | 0.98 / g |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Fungilyse 1 %
Fungilyse 1 % belongs to the antifungals for dermatological use therapeutic class. In Morocco, this drug is marketed by LAPROPHAN and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Fungilyse 1 %, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Fungilyse 1 %
Answers to common questions from Moroccan patients about this drug.